This is a five-year competitive renewal application from the GCRC Program at the University of Southern California. The program has been funded continuously for 36 years and has undergone two very major changes since the last site visit three years ago. 1. The Parent GCRC program at Los Angeles Country - University of Southern California Medical Center opened a new 9,693 square foot facility on July 24, 1994. The new unit has a 6-bed outpatient study area and a 14 bed inpatient ward with isolation rooms and a 3-bed area that is convertible for outpatient studies. CDMAS and biostatistical facilities and administrative offices. The opening of this facility has been followed by a remarkable increase in utilization by investigators from a variety of disciplines. 2. On July 21, 1995, we celebrated the opening of a new Satellite GCRC at Children's Hospital of Los Angeles. The unit features cutting edge research in human gene therapy and bone marrow transplantation, for which it provides unique core lab facilities. The new satellite has already experienced remarkable growth with addition of programs in HIV infection and neurological and oncological disorders in children. The Parent and Satellite GCRCs have integrated their administrative leadership and Scientific Advisory Committee and they have developed joint training and biostatistical support programs. The addition of the Satellite GCRC has expanded the breadth of scientific activities to the mutual benefit of both Units. In the next grant cycle, major research directions at the Parent GCRC will take advantage of our unique patient populations to conduct: 1) large population studies of the pathogenesis of complex disease (hypertension, diabetes, atherosclerosis); 2) studies of HIV and HIV related diseases in children and adults; 3) disease prevention, including three separate diabetes prevention programs in high risk minority groups. We will also continue to develop our Molecular Medicine Core facility. The focus for the Satellite GCRC in the next cycle will be on gene therapy, gene studies of HIV infection, and diversification of the research programs that use the new facility. We have entered a period of remarkable growth-fostered by GCRC support and driven by the success of our investigators in obtaining peer-reviewed funding. We look forward to continued growth and success in the next grant cycle.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
2M01RR000043-38
Application #
2371242
Study Section
Special Emphasis Panel (ZRR1-GCRC-3 (01))
Project Start
1974-10-01
Project End
2002-11-30
Budget Start
1997-12-01
Budget End
1998-11-30
Support Year
38
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Southern California
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Kelsey, Megan M; Braffett, Barbara H; Geffner, Mitchell E et al. (2018) Menstrual Dysfunction in Girls From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. J Clin Endocrinol Metab 103:2309-2318
Davis, J N; Asigbee, F M; Markowitz, A K et al. (2018) Consumption of artificial sweetened beverages associated with adiposity and increasing HbA1c in Hispanic youth. Clin Obes 8:236-243
Kleinberger, Jeffrey W; Copeland, Kenneth C; Gandica, Rachelle G et al. (2018) Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial. Genet Med 20:583-590
Berkowitz, Robert I; Marcus, Marsha D; Anderson, Barbara J et al. (2018) Adherence to a lifestyle program for youth with type 2 diabetes and its association with treatment outcome in the TODAY clinical trial. Pediatr Diabetes 19:191-198
Kriska, Andrea; El Ghormli, Laure; Copeland, Kenneth C et al. (2018) Impact of lifestyle behavior change on glycemic control in youth with type 2 diabetes. Pediatr Diabetes 19:36-44
Venditti, E M; Tan, K; Chang, N et al. (2018) Barriers and strategies for oral medication adherence among children and adolescents with Type 2 diabetes. Diabetes Res Clin Pract 139:24-31
Detterich, Jon A (2018) Simple chronic transfusion therapy, a crucial therapeutic option for sickle cell disease, improves but does not normalize blood rheology: What should be our goals for transfusion therapy? Clin Hemorheol Microcirc 68:173-186
Gidding, Samuel S; Bacha, Fida; Bjornstad, Petter et al. (2018) Cardiac Biomarkers in Youth with Type 2 Diabetes Mellitus: Results from the TODAY Study. J Pediatr 192:86-92.e5
Manosroi, Worapaka; Tan, Jia Wei; Rariy, Chevon M et al. (2017) The Association of Estrogen Receptor-? Gene Variation With Salt-Sensitive Blood Pressure. J Clin Endocrinol Metab 102:4124-4135
Cooper, Aaron R; Lill, Georgia R; Shaw, Kit et al. (2017) Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients. Blood 129:2624-2635

Showing the most recent 10 out of 565 publications